Show simple item record

dc.contributor.authorGross, Kenneth M.en_US
dc.contributor.authorBremner, William J.en_US
dc.date.accessioned2008-10-17T20:42:54Z
dc.date.available2008-10-17T20:42:54Z
dc.date.issued1987-08en_US
dc.identifier.citationAm J Med. 1987 Aug;83(2):359-61en_US
dc.identifier.urihttp://hdl.handle.net/1773/4445
dc.description.abstractA 60-year-old man with stage D2 prostatic carcinoma received treatment with a new luteinizing hormone-releasing hormone superagonist. After a seven-month remission; relapse of the disease occurred and an adrenal-suppressing dose of dexamethasone was added. The resulting combined gonadal and adrenal suppression led to another remission that lasted five months. This case supports other observations of the importance of adrenal androgen production in the pathobiology of prostatic carcinoma.en_US
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.subject5-alpha reductase inhibitorsen_US
dc.subjectgonadotropinsen_US
dc.subjecttestosteroneen_US
dc.subjectreifenstein's syndromeen_US
dc.subjectklinefelter's syndromeen_US
dc.subjectspermatogenesisen_US
dc.subjectandrologyen_US
dc.subjectmale contraceptionen_US
dc.subjectcolchicineen_US
dc.subject.meshLymphatic Metastasisen_US
dc.subject.meshHumansen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshNeoplasm Recurrence, Local, drug therapy, pathologyen_US
dc.subject.meshMaleen_US
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols, therapeutic useen_US
dc.subject.meshResearch Support, U.S. Gov't, Non-P.H.S.en_US
dc.subject.meshProstate, pathologyen_US
dc.subject.meshProstatic Neoplasms, drug therapy, pathologyen_US
dc.subject.meshTime Factorsen_US
dc.subject.meshNafarelinen_US
dc.subject.meshDexamethasone, administration & dosageen_US
dc.subject.meshGonadorelin, administration & dosage, analogs & derivativesen_US
dc.subject.meshBiopsyen_US
dc.subject.meshRemission Inductionen_US
dc.subject.meshAdenocarcinoma, drug therapy, pathologyen_US
dc.subject.meshResearch Support, U.S. Gov't, P.H.S.en_US
dc.titleTreatment of stage D2 prostatic carcinoma with combined gonadal and adrenal suppression in a 60-year-old manen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record